Lost your password?
Don't have an account? Sign Up

Biogen Stock Surges After Study Shows Its Drug Slows Alzheimer’s

Biogen shares surged some 37% in afternoon trading!

That happened after the company said its experimental Alzheimer’s drug had significantly slowed the disease’s progression in a large study, Biogen reports

Tweet on the latest alzheimer’s drug by Biogen

Stock in its partner in the study, Japanese pharmaceutical firm Eisai, jumped in Tokyo trading

Shares in some other drugmakers also surged, with Eli Lilly adding about 8% and the U.S.-listed shares of Roche Holding adding nearly 7%.

  • Biogen was by far the best performer on the S&P 500.
  • An estimated six million people in the U.S. suffer from Alzheimer’s.

Currently available treatments can help temporarily alleviate some symptoms, but none affect the overall course of disease.



source: Biogen